{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:45:34Z","timestamp":1792003534386,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012832","name":"Okinaka Memorial Institute for Medical Research","doi-asserted-by":"publisher","award":["DRR446388-DRR446393"],"award-info":[{"award-number":["DRR446388-DRR446393"]}],"id":[{"id":"10.13039\/100012832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cyto.2024.156587","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T06:13:00Z","timestamp":1711347180000},"page":"156587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis: Investigating the potential effect and mechanism of brodalumab"],"prefix":"10.1016","volume":"178","author":[{"given":"Kazuki M.","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyoshi","family":"Hisamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Kuzumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemichi","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Yoshizaki-Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156587_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2024.156587_b0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of patients with cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156587_b0015","first-page":"1","volume":"2","author":"Greb","year":"2016","journal-title":"Psoriasis. Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cyto.2024.156587_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cyto.2024.156587_b0025","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2024.156587_b0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.cyto.2024.156587_b0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2024.156587_b0040","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/hep.26746","article-title":"IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice","volume":"59","author":"Harley","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2024.156587_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149783","article-title":"Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis","volume":"11","author":"Giles","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156587_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and enrichment analyses of non- alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.cyto.2024.156587_b0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of Interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156587_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/20.19.5332","article-title":"IL-17s adopt a cystine knot fold : structure and activity of a novel cytokine, IL-17F, and implications for receptor binding","volume":"20","author":"Hymowitz","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2024.156587_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a Heteromeric receptor complex","volume":"177","author":"Toy","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156587_b0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a Heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156587_b0075","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3109\/00365520903312441","article-title":"Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis","volume":"44","author":"Hu","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.cyto.2024.156587_b0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2009.09.015","article-title":"Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition","volume":"138","author":"Kluwe","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2024.156587_b0085","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.cyto.2024.156587_b0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S","article-title":"Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells","volume":"187","author":"Inagaki","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cyto.2024.156587_b0095","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1400861","article-title":"IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-\u03b2 receptor on hepatic stellate cells in a JNK-dependent manner","volume":"193","author":"Fabre","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156587_b0100","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 studies Comparing brodalumab with ustekinumab in psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2024.156587_b0105","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/annrheumdis-2020-219406","article-title":"Efficacy and safety of brodalumab, an anti-IL17RA \u00admonoclonal antibody, in patients with axial spodyloarthritis: 16-week results from a randomised, controlled, phase 3 trial","volume":"80","author":"Wei","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2024.156587_b0110","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s13555-022-00760-8","article-title":"Efficacy of bimekizumab and other biologics in moderate to severe plaque psoriasis : a systematic literature review and a network meta-analysis","volume":"12","author":"Armstrong","year":"2022","journal-title":"Dermatol. Ther. (heidelb)"},{"key":"10.1016\/j.cyto.2024.156587_b0115","first-page":"516","article-title":"Interleukin-17 pathway inhibition with brodalumab in early systemic sclerosis: analysis of a single-arm, open-label, phase 1 trial","volume":"23","author":"Fukasawa","year":"2023","journal-title":"J. Am. Acad. Dermatology"},{"key":"10.1016\/j.cyto.2024.156587_b0120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2022-eular.2519","article-title":"Effiacy and safety of subcutaneous brodalumab, a fully human anti-IL-17RA monoclonal antibody, for systemic sclerosis with moderate-to-severe skin thickening: a multicenter, randomized, placebo-controlled, double-blind phase 3 study","volume":"81","author":"Fukasawa","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2024.156587_b0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2024.156587_b0130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00535-012-0704-y","article-title":"Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels","volume":"48","author":"Yoneda","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cyto.2024.156587_b0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab Anim."},{"key":"10.1016\/j.cyto.2024.156587_b0140","doi-asserted-by":"crossref","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","author":"Machado","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156587_b0145","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cyto.2024.156587_b0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human Hepatic Stellate Cell Lines, LX-1 and LX-2: New Tools for Analysis of Hepatic Fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":". Gut"},{"key":"10.1016\/j.cyto.2024.156587_b0155","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cyto.2024.156587_b0160","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cyto.2024.156587_b0165","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.cyto.2024.156587_b0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2105-14-219","article-title":"TCC : an R package for comparing tag count data with robust normalization strategies TCC : an R package for comparing tag count data with robust normalization strategies","volume":"14","author":"Sun","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.cyto.2024.156587_b0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13104-019-4179-2","article-title":"TCC-GUI: a shiny-based application for differential expression analysis of RNA-seq count data","volume":"12","author":"Su","year":"2019","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.cyto.2024.156587_b0180","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2024.156587_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.pone.0080747","article-title":"PaGenBase : a pattern gene database for the global and dynamic understanding of gene function","volume":"8","author":"Pan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156587_b0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cyto.2024.156587_b0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O","article-title":"Interaction of Smad3 with a proximal smad-binding element of the human \u03b12(I) procollagen gene promoter required for transcriptional activation by TGF-\u03b2","volume":"392","author":"Chen","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cyto.2024.156587_b0200","first-page":"59","article-title":"Experimental models of liver fibrosis","volume":"18","author":"Yanguas Bruno","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2024.156587_b0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","article-title":"Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model","volume":"33","author":"Weber","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.cyto.2024.156587_b0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.cyto.2024.156587_b0215","series-title":"Origin of myofibroblasts in the fibrotic liver in mice","first-page":"111","author":"Iwaisako","year":"2014"},{"key":"10.1016\/j.cyto.2024.156587_b0220","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-\u03b1 production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2024.156587_b0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156587_b0230","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156587_b0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2020.02.004","article-title":"Structural analysis reveals that the cytokine IL-17F forms a Homodimeric complex with receptor IL- article structural analysis reveals that the cytokine IL-17F forms a Homodimeric complex with receptor","volume":"52","author":"Goepfert","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156587_b0240","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/1346-8138.15508","article-title":"Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis","volume":"47","author":"Fukayama","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cyto.2024.156587_b0245","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2024.156587_b0250","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2024.156587_b0255","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrm2755","article-title":"Pathways and mechanisms of endocytic recycling","volume":"10","author":"Grant","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cyto.2024.156587_b0260","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4049\/jimmunol.1801025","article-title":"IL-17A recruits Rab35 to IL-17R to mediate PKC \u03b1 -dependent stress fiber formation and airway smooth muscle Contractility","volume":"202","author":"Bulek","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156587_b0265","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/biom11091340","article-title":"The regulation of Rab GTPases by phosphorylation","volume":"11","author":"Xu","year":"2021","journal-title":"Biomolecules"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:40:25Z","timestamp":1778794825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"alternative-id":["S1043466624000905"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156587","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis: Investigating the potential effect and mechanism of brodalumab","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156587"}}